The genetic background of gallstone formation: An update

Biochemical and Biophysical Research Communications

Volumn 396, Issue 1, 2010, Pages 58-62

  Marschall, Hanns Ulrich ^a   Katsika, Despina ^a   Rudling, Mats ^a   Einarsson, Curt ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Association study; ATP binding cassette transporter; Gallstones; Lithogenic genes; Swedish Twin Registry

Indexed keywords

ABC TRANSPORTER B11; ABC TRANSPORTER G4; ABC TRANSPORTER G5; ABC TRANSPORTER G8; ANDROGEN RECEPTOR; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN C1; BETA 3 ADRENERGIC RECEPTOR; CARRIER PROTEIN; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; ESTROGEN RECEPTOR BETA; FARNESOID X RECEPTOR; FIBROBLAST GROWTH FACTOR 19; FIBROBLAST GROWTH FACTOR RECEPTOR 4; GLUCURONOSYLTRANSFERASE 1A1; LIVER X RECEPTOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MULTIDRUG RESISTANCE PROTEIN 3; UNCLASSIFIED DRUG;

ARTICLE; CHOLELITHIASIS; CHOLESTEROL STONE; CHOLESTEROL SYNTHESIS; GALLSTONE FORMATION; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEREDITY; HUMAN; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; RISK FACTOR;

BILE PIGMENTS; GALLSTONES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; P-GLYCOPROTEINS;

EID: 77952307855     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.02.143     Document Type: Article

References (60)

1. Lammert F., and Sauerbruch T. Mechanisms of disease: the genetic epidemiology of gallbladder stones. Nat. Clin. Pract. Gastroenterol. Hepatol. 2 (2005) 423-433
2. Portincasa P., Moschetta A., and Palasciano G. Cholesterol gallstone disease. Lancet 368 (2006) 230-239
3. Marschall H.U., and Einarsson C. Gallstone disease. J. Intern. Med. 261 (2007) 529-542
4. Maurer K.J., Carey M.C., and Fox J.G. Roles of infection, inflammation, and the immune system in cholesterol gallstone formation. Gastroenterology 136 (2009) 425-440
5. Katsika D., Grjibovski A., Einarsson C., Lammert F., Lichtenstein P., and Marschall H.U. Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs. Hepatology 41 (2005) 1138-1143
6. Nakeeb A., Comuzzie A.G., Martin L., Sonnenberg G.E., Swartz-Basile D., Kissebah A.H., and Pitt H.A. Gallstones: genetics versus environment. Ann. Surg. 235 (2002) 842-849
7. Katsika D., Tuvblad C., Einarsson C., Lichtenstein P., and Marschall H.U. Body mass index, alcohol, tobacco and symptomatic gallstone disease: a Swedish twin study. J. Intern. Med. 262 (2007) 581-587
8. Lyons M.A., and Wittenburg H. Cholesterol gallstone susceptibility loci: a mouse map, candidate gene evaluation, and guide to human LITH genes. Gastroenterology 131 (2006) 1943-1970
9. Wittenburg H., Lyons M.A., Li R., Churchill G.A., Carey M.C., and Paigen B. FXR and ABCG5/ABCG8 as determinants of cholesterol gallstone formation from quantitative trait locus mapping in mice. Gastroenterology 125 (2003) 868-881
10. Yu L., Hammer R.E., Li-Hawkins J., Von Bergmann K., Lutjohann D., Cohen J.C., and Hobbs H.H. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc. Natl. Acad. Sci. USA 99 (2002) 16237-16242
11. Puppala S., Dodd G.D., Fowler S., Arya R., Schneider J., Farook V.S., Granato R., Dyer T.D., Almasy L., Jenkinson C.P., Diehl A.K., Stern M.P., Blangero J., and Duggirala R. A genomewide search finds major susceptibility loci for gallbladder disease on chromosome 1 in Mexican Americans. Am. J. Hum. Genet. 78 (2006) 377-392
12. Buch S., Schafmayer C., Volzke H., Becker C., Franke A., von Eller-Eberstein H., Kluck C., Bassmann I., Brosch M., Lammert F., Miquel J.F., Nervi F., Wittig M., Rosskopf D., Timm B., Holl C., Seeger M., ElSharawy A., Lu T., Egberts J., Fandrich F., Folsch U.R., Krawczak M., Schreiber S., Nurnberg P., Tepel J., and Hampe J. A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease. Nat. Genet. 39 (2007) 995-999
13. Grunhage F., Acalovschi M., Tirziu S., Walier M., Wienker T.F., Ciocan A., Mosteanu O., Sauerbruch T., and Lammert F. Increased gallstone risk in humans conferred by common variant of hepatic ATP-binding cassette transporter for cholesterol. Hepatology 46 (2007) 793-801
14. Kuo K.K., Shin S.J., Chen Z.C., Yang Y.H., Yang J.F., and Hsiao P.J. Significant association of ABCG5 604Q and ABCG8 D19H polymorphisms with gallstone disease. Br. J. Surg. 95 (2008) 1005-1011
15. Wang Y., Jiang Z.Y., Fei J., Xin L., Cai Q., Jiang Z.H., Zhu Z.G., Han T.Q., and Zhang S.D. ATP binding cassette G8 T400K polymorphism may affect the risk of gallstone disease among Chinese males. Clin. Chim. Acta 384 (2007) 80-85
16. D. Katsika, P. Magnusson, M. Krawczyk, F. Grünhage, P. Lichtenstein, C. Einarsson, F. Lammert, H.U. Marschall, Gallstone disease in Swedish twins is associated to ABCG8D19H risk genotype, submitted for publication.
17. Berge K.E., von Bergmann K., Lutjohann D., Guerra R., Grundy S.M., Hobbs H.H., and Cohen J.C. Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8. J. Lipid Res. 43 (2002) 486-494
18. Gylling H., Hallikainen M., Pihlajamaki J., Agren J., Laakso M., Rajaratnam R.A., Rauramaa R., and Miettinen T.A. Polymorphisms in the ABCG5 and ABCG8 genes associate with cholesterol absorption and insulin sensitivity. J. Lipid Res. 45 (2004) 1660-1665
19. Acalovschi M., Ciocan A., Mostean O., Tirziu S., Chiorean E., Keppeler H., Schirin-Sokhan R., and Lammert F. Are plasma lipid levels related to ABCG5/ABCG8 polymorphisms? A preliminary study in siblings with gallstones. Eur. J. Intern. Med. 17 (2006) 490-494
20. Kajinami K., Brousseau M.E., Nartsupha C., Ordovas J.M., and Schaefer E.J. ATP binding cassette transporter G5 and G8 genotypes and plasma lipoprotein levels before and after treatment with atorvastatin. J. Lipid Res. 45 (2004) 653-656
21. Jiang Z.Y., Parini P., Eggertsen G., Davis M.A., Hu H., Suo G.J., Zhang S.D., Rudel L.L., Han T.Q., and Einarsson C. Increased expression of LXR alpha, ABCG5, ABCG8, and SR-BI in the liver from normolipidemic, nonobese Chinese gallstone patients. J. Lipid Res. 49 (2008) 464-472
22. Jiang Z.Y., Jiang C.Y., Wang L., Wang J.C., Zhang S.D., Einarsson C., Eriksson M., Han T.Q., Parini P., and Eggertsen G. Increased NPC1L1 and ACAT2 expression in the jejunal mucosa from Chinese gallstone patients. Biochem. Biophys. Res. Commun. 379 (2009) 49-54
23. Chen Z.C., Shin S.J., Kuo K.K., Lin K.D., Yu M.L., and Hsiao P.J. Significant association of ABCG8:D19H gene polymorphism with hypercholesterolemia and insulin resistance. J. Hum. Genet. 53 (2008) 757-763
24. Rosmorduc O., Hermelin B., Boelle P.Y., Parc R., Taboury J., and Poupon R. ABCB4 gene mutation-associated cholelithiasis in adults. Gastroenterology 125 (2003) 452-459
25. Rosmorduc O., Hermelin B., and Poupon R. MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis. Gastroenterology 120 (2001) 1459-1467
26. -/- mice: a model for low phospholipid-associated cholelithiasis. Hepatology 39 (2004) 117-128
27. Jacquemin E., De Vree J.M., Cresteil D., Sokal E.M., Sturm E., Dumont M., Scheffer G.L., Paul M., Burdelski M., Bosma P.J., Bernard O., Hadchouel M., and Elferink R.P. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology 120 (2001) 1448-1458
28. Geenes V., and Williamson C. Intrahepatic cholestasis of pregnancy. World J. Gastroenterol. 15 (2009) 2049-2066
29. Wasmuth H.E., Glantz A., Keppeler H., Simon E., Bartz C., Rath W., Mattsson L.A., Marschall H.U., and Lammert F. Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter ABCB4 gene. Gut 56 (2007) 265-270
30. Glantz A., Marschall H.U., and Mattsson L.A. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology 40 (2004) 467-474
31. Sangfeld P., Lammert F., and Marschall H.U. Co-inheritance of ABCB4 and ABCG8 variants in a Swedish twin pair with juvenile onset gallstone disease and oral contraceptive and pregnancy aggravated cholestatic liver disease. Gastroenterology 136 (2009) A855
32. Nakken K.E., Labori K.J., Rodningen O.K., Nakken S., Berge K.E., Eiklid K., and Raeder M.G. ABCB4 sequence variations in young adults with cholesterol gallstone disease. Liver Int. 29 (2009) 743-747
33. van Mil S.W., van der Woerd W.L., van der Brugge G., Sturm E., Jansen P.L., Bull L.N., van den Berg I.E., Berger R., Houwen R.H., and Klomp L.W. Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11. Gastroenterology 127 (2004) 379-384
34. Acalovschi M., Tirziu S., Chiorean E., Krawczyk M., Grunhage F., and Lammert F. Common variants of ABCB4 and ABCB11 and plasma lipid levels: a study in sib pairs with gallstones, and controls. Lipids 44 (2009) 521-526
35. Dixon P.H., van Mil S.W., Chambers J., Strautnieks S., Thompson R.J., Lammert F., Kubitz R., Keitel V., Glantz A., Mattsson L.A., Marschall H.U., Molokhia M., Moore G.E., Linton K.J., and Williamson C. Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy. Gut 58 (2009) 537-544
36. Zollner G., Marschall H.U., Wagner M., and Trauner M. Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations. Mol. Pharm. 3 (2006) 231-251
37. Lefebvre P., Cariou B., Lien F., Kuipers F., and Staels B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol. Rev. 89 (2009) 147-191
38. Lundasen T., Galman C., Angelin B., and Rudling M. Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. J. Intern. Med. 260 (2006) 530-536
39. Renner O., Harsch S., Strohmeyer A., Schimmel S., and Stange E.F. Reduced ileal expression of OSTalpha-OSTbeta in non-obese gallstone disease. J. Lipid Res. 49 (2008) 2045-2054
40. Hofmann A.F., Mangelsdorf D.J., and Kliewer S.A. Chronic diarrhea due to excessive bile acid synthesis and not defective ileal transport: a new syndrome of defective fibroblast growth factor 19 release. Clin. Gastroenterol. Hepatol. 7 (2009) 1151-1154
41. Pullinger C.R., Eng C., Salen G., Shefer S., Batta A.K., Erickson S.K., Verhagen A., Rivera C.R., Mulvihill S.J., Malloy M.J., and Kane J.P. Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J. Clin. Invest. 110 (2002) 109-117
42. Jiang Z.Y., Han T.Q., Suo G.J., Feng D.X., Chen S., Cai X.X., Jiang Z.H., Shang J., Zhang Y., Jiang Y., and Zhang S.D. Polymorphisms at cholesterol 7alpha-hydroxylase, apolipoproteins B and E and low density lipoprotein receptor genes in patients with gallbladder stone disease. World J. Gastroenterol. 10 (2004) 1508-1512
43. Kovacs P., Kress R., Rocha J., Kurtz U., Miquel J.F., Nervi F., Mendez-Sanchez N., Uribe M., Bock H.H., Schirin-Sokhan R., Stumvoll M., Mossner J., Lammert F., and Wittenburg H. Variation of the gene encoding the nuclear bile salt receptor FXR and gallstone susceptibility in mice and humans. J. Hepatol. 48 (2008) 116-124
44. Van Mil S.W., Milona A., Dixon P.H., Mullenbach R., Geenes V.L., Chambers J., Shevchuk V., Moore G.E., Lammert F., Glantz A.G., Mattsson L.A., Whittaker J., Parker M.G., White R., and Williamson C. Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy. Gastroenterology 133 (2007) 507-516
45. Renner O., Harsch S., Schaeffeler E., Winter S., Schwab M., Krawczyk M., Rosendahl J., Wittenburg H., Lammert F., and Stange E.F. A variant of the SLC10A2 gene encoding the apical sodium-dependent bile acid transporter is a risk factor for gallstone disease. PLoS One 4 (2009) e7321
46. Dixit M., Choudhuri G., Saxena R., and Mittal B. Association of apolipoprotein A1-C3 gene cluster polymorphisms with gallstone disease. Can. J. Gastroenterol. 21 (2007) 569-575
47. Han T., Jiang Z., Suo G., and Zhang S. Apolipoprotein B-100 gene Xba I polymorphism and cholesterol gallstone disease. Clin. Genet. 57 (2000) 304-308
48. Kurzawski M., Juzyszyn Z., Modrzejewski A., Pawlik A., Wiatr M., Czerny B., Adamcewicz R., and Drozdzik M. Apolipoprotein B (APOB) gene polymorphism in patients with gallbladder disease. Arch. Med. Res. 38 (2007) 360-363
49. Lancellotti S., Zaffanello M., Di Leo E., Costa L., Lonardo A., and Tarugi P. Pediatric gallstone disease in familial hypobetalipoproteinemia. J. Hepatol. 43 (2005) 188-191
50. Dixit M., Choudhuri G., and Mittal B. Association of APOE-C1 gene cluster polymorphisms with gallstone disease. Dig. Liver Dis. 38 (2006) 397-403
51. Miller L.J., Holicky E.L., Ulrich C.D., and Wieben E.D. Abnormal processing of the human cholecystokinin receptor gene in association with gallstones and obesity. Gastroenterology 109 (1995) 1375-1380
52. Dixit M., Choudhuri G., and Mittal B. Association of lipoprotein receptor, receptor-associated protein, and metabolizing enzyme gene polymorphisms with gallstone disease: a case-control study. Hepatol. Res. 36 (2006) 61-69
53. Klass D.M., Lauer N., Hay B., Kratzer W., and Fuchs M. Arg64 variant of the beta3-adrenergic receptor is associated with gallstone formation. Am. J. Gastroenterol. 102 (2007) 2482-2487
54. Kitsiou-Tzeli S., Giannatou E., Spanos I., Nicolaidou P., Fretzayas A., Tzetis M., Lazaris D., Kanavakis E., and Tsezou A. Steroid hormones polymorphisms and cholelithiasis in Greek population. Liver Int. 27 (2007) 61-68
55. Lammert F., and Sauerbruch T. Pathogenesis of gallstone formation: updated inventory of human lithogenic genes. In: Carey M., Dité P., Gabryelewicz A., Keim V., and Mörner J. (Eds). Future Perspectives in Gastroenterology (Falk Symposium 161) (2008), Springer, Dordrecht, The Netherlands 99-107
56. Wang D.Q., Cohen D.E., and Carey M.C. Biliary lipids and cholesterol gallstone disease. J. Lipid Res. 50 Suppl. (2009) S406-S411
57. Vasavda N., Menzel S., Kondaveeti S., Maytham E., Awogbade M., Bannister S., Cunningham J., Eichholz A., Daniel Y., Okpala I., Fulford T., and Thein S.L. The linear effects of alpha-thalassaemia, the UGT1A1 and HMOX1 polymorphisms on cholelithiasis in sickle cell disease. Br. J. Haematol. 138 (2007) 263-270
58. Wasmuth H.E., Keppeler H., Herrmann U., Schirin-Sokhan R., Barker M., and Lammert F. Coinheritance of Gilbert syndrome-associated UGT1A1 mutation increases gallstone risk in cystic fibrosis. Hepatology 43 (2006) 738-741
59. Tsezou A., Tzetis M., Giannatou E., Spanos I., Roma E., Fretzayas A., Kanavakis E., and Kitsiou-Tzeli S. Gilbert syndrome as a predisposing factor for cholelithiasis risk in the Greek adult population. Genet. Test Mol. Biomarkers 13 (2009) 143-146
60. Johnson A.D., Kavousi M., Smith A.V., Chen M.H., Dehghan A., Aspelund T., Lin J.P., van Duijn C.M., Harris T.B., Cupples L.A., Uitterlinden A.G., Launer L., Hofman A., Rivadeneira F., Stricker B., Yang Q., O'Donnell C.J., Gudnason V., and Witteman J.C. Genome-wide association meta-analysis for total serum bilirubin levels. Hum. Mol. Genet. 18 (2009) 2700-2710